Published 11 June 2026 · DaXem GmbH editorial · Reading time ~6 minutes · Based on Almeida-Pinto, Pinto & Rocha (2024), Infectious Diseases and Therapy In short: A January 2024 peer-reviewed review in Infectious Diseases and Therapy maps the treatment landscape for Ebola virus disease (EVD). Two antibody therapies — Read more
Antimicrobial Surface Coating: Why Disinfection Alone Is Not Enough | VireXbuster Antimicrobial Surface Coating: Why Disinfection Alone Is Not Enough Short answer: Standard disinfection kills pathogens only at the moment of application. Within minutes of cleaning, surfaces are re-contaminated by touch, air, and droplets. An antimicrobial surface coating creates a Read more
By DaXem GmbH · May 29, 2026 · 5 min read · VireXbuster Blog Clean vs. Hygienic: The Critical Difference That Changes Everything The short answer: A surface can look mirror-clean and still be teeming with live MRSA or Norovirus particles. “Clean” is a visual status. “Hygienic” is a biological Read more
Ebola Suspected in Como, Italy: What It Means for Surface Biosecurity | VireXbuster® 🔴 Breaking Suspected Ebola cases detected in Como province, Lombardy — May 25, 2026 VireXbuster® Shop Now 🔬 Biosecurity Alert Ebola Reaches Northern Italy:Is Your Facility Ready? Two suspected Ebola (Bundibugyo) cases have been detected in the Read more
By DaXem GmbH | virexbuster.de | Published: 21 May 2026 Quick answer: Nosocomial (hospital-acquired) infections affect approximately 3.8 million EU patients every year. A major contributing factor is the gap between disinfection events: surfaces are re-contaminated within minutes of cleaning. VireXbuster is a Supplemental Residual Antimicrobial Product (EPA classification) that Read more
Healthcare Biocontainment & Viral Outbreak Prevention | VireXbuster EPA Antimicrobial Product Healthcare Biocontainment: Preventing Viral Outbreaks with Antimicrobial coating Published: May 18, 2026 | Category: Healthcare & Biocontainment | Read Time: 8 minutes High-consequence infectious diseases like Ebola demand uncompromising surface antimicrobial protection. Healthcare facilities, biocontainment units, and isolation wards Read more
Antimicrobial Resistance in Pharmacies 2026: Why Surface Protection Is No Longer Optional | VireXbuster 🛡 VireXbuster.de DaXem GmbH · Eschborn, Germany · info@daxem.de ⚠ Infection Control Alert · May 12, 2026 Antimicrobial Resistance in Pharmacies 2026:Why Surface Protection Is No Longer Optional Italy records the highest AMR mortality in Europe. Read more
Hantavirus Outbreak 2026: What Disinfectants Kill Andes Virus | VireXbuster VireXbuster Order Now Home › Blog › Hantavirus Disinfection 2026 Photo: CDC / Unsplash — Free to use under Unsplash License ⚠ Breaking — May 11, 2026 Hantavirus Outbreak 2026: What Disinfectants Kill Andes Virus — and What the MV Read more
One Disinfectant to Rule Them All: Why Broad-Spectrum Protection Is the Future of Hygiene in 2026 | VireXbuster Home › Blog › Broad-Spectrum Disinfectant 2026 Hygiene & Health One Disinfectant to Rule Them All: Why Broad-Spectrum Protection Is the Future of Hygiene in 2026 Published: May 5, 2026 Author: DaXem Read more
In regulated industries — pharmaceutical manufacturing, medical device production, clinical laboratories, and life science research — “we believe our product works” is not good enough. Procurement managers, quality assurance officers, and infection-control teams demand independent, reproducible, third-party evidence. That is exactly why DaXem GmbH had VireXbuster® tested by two leading Read more
